Nordic Bioproducts Group is a leading manufacturer specialising in the production of sustainable microcrystalline cellulose (MCC) for the pharmaceutical industry. The company is recognised for its commitment to biomaterial innovation, harnessing the power of lignocellulose to create high-quality excipients that significantly reduce environmental impact. Operating from their production facility in Finland, which is certified to ISO 9001:2015 and EXCiPACT standards, Nordic Bioproducts ensures that its products meet the highest quality benchmarks while embracing sustainability.

Services include:
– Excipients
– Microcrystalline cellulose production
– Customised formulations

Committed to sustainable practices, Nordic Bioproducts Group aims to provide the pharmaceutical sector with innovative solutions that meet the growing demand for eco-friendly materials. For more information, please visit nordicbioproducts.fi.